Study Shows How Vaping Can Damage Your Airway

New Cleveland Clinic research shows how e-cigarettes and vaping can damage your airway and also put you at risk for viral infections.

Translate to Spanish or other 102 languages!

According to researchers, the popular devices have been shown to damage cells that protect your airway. Image for illustration purposes
According to researchers, the popular devices have been shown to damage cells that protect your airway. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – A Cleveland Clinic study is highlighting the dangers of e-cigarettes and vaping

According to researchers, the popular devices have been shown to damage cells that protect your airway. 
 
“Why is this important? Because if the integrity of the airway barrier is disrupted, everything can get in, viruses can get in, or other pollutions or allergens can get in,” explained Fariba Rezaee, MD, pediatric pulmonologist for Cleveland Clinic Children’s.   
 
Dr. Rezaee said they created a breathing simulator for the study, and then tested different devices and flavors to see how they would impact cells in the airway. 

She said they discovered that no matter the device, or flavors introduced, they all caused harm. 

- Advertisement -

However, the combination of flavor and nicotine were said to be the worst.  

They also learned that the use of e-cigarettes or vapes can put a person at greater risk for viral infections, like RSV.
 
“We exposed the cells to the aerosols generated by this machine, and then we did the viral infection, and we saw that the effect was worse,” she noted. “So basically we saw more viral infections and more damage to the airway epithelial cells.”  
 
Dr. Rezaee said more research needs to be done on the long-term effects. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Smart Strategies to Fight Childhood Obesity Today

As kids head back to school and new routines are established, pediatricians are warning of the long-term consequences of obesity.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.

Why Science Says to Ditch Hydrogen Peroxide for Wounds

Growing up, you may have heard that you should treat open wounds with hydrogen peroxide, but that’s no longer the case.

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
- Advertisement -